GBM progression seems to depend on the PI3K/Akt pathway, which promotes cell proliferation, angiogenesis, migration, invasion and metabolic reprogramming (Su et al., 2021), making it a potential therapeutic target (Lee et al., 2021). Here, AKT1 is linked to glioblastoma.